Genotype 3: Treat now or wait for something better?
- PMID: 31041008
- PMCID: PMC6490668
- DOI: 10.1002/cld.510
Genotype 3: Treat now or wait for something better?
References
-
- World Health Organization . Hepatitis C. http://www.who.int/mediacentre/factsheets/fs164/en/. Updated July 2015. Accessed July 29, 2015.
-
- Bochud PY, Cai T, Overbeck K, Bochud M, Dufour JF, Müllhaupt B, et al.; Swiss Hepatitis C Cohort Study Group . Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. J Hepatol 2009;51:655‐666. - PubMed
-
- Lawitz E, Mangia A, Wyles D, Rodriguez‐Torres M, Hassanein T, Gordon SC, et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med 2013;368:1878‐1887. - PubMed
-
- Jacobson IM, Gordon SC, Kowdley KV, Yoshida EM, Rodriguez‐Torres M, Sulkowski MS, et al.; POSITRON Study ; FUSION Study . Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. N Engl J Med 2013;368:1867‐1877. - PubMed
-
- Zeuzem S, Dusheiko GM, Salupere R, Mangia A, Flisiak R, Hyland RH, et al.; VALENCE Investigators . Sofosbuvir and ribavirin in HCV genotypes 2 and 3. N Engl J Med 2014;370:1993‐2001. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
